Advance of promising targets and agents against COVID-19 in China.
Identifieur interne : 001A56 ( Main/Curation ); précédent : 001A55; suivant : 001A57Advance of promising targets and agents against COVID-19 in China.
Auteurs : Yongtao Duan [République populaire de Chine] ; Hai-Liang Zhu [République populaire de Chine] ; Chongchen Zhou [République populaire de Chine]Source :
- Drug discovery today [ 1878-5832 ] ; 2020.
Descripteurs français
- KwdFr :
- AMP (analogues et dérivés), AMP (usage thérapeutique), Adénine (analogues et dérivés), Adénine (usage thérapeutique), Alanine (analogues et dérivés), Alanine (usage thérapeutique), Amides (usage thérapeutique), Antipaludiques (usage thérapeutique), Antiviraux (usage thérapeutique), Association de médicaments (MeSH), Association médicamenteuse (MeSH), Betacoronavirus (métabolisme), Chine (MeSH), Chloroquine (usage thérapeutique), Cobicistat (usage thérapeutique), Cysteine endopeptidases (métabolisme), Dibenzothiépines (MeSH), Découverte de médicament (MeSH), Emtricitabine (usage thérapeutique), Essais cliniques comme sujet (MeSH), Glycoprotéine de spicule des coronavirus (métabolisme), Humains (MeSH), Hydroxychloroquine (usage thérapeutique), Indoles (usage thérapeutique), Infections à coronavirus (traitement médicamenteux), Lopinavir (usage thérapeutique), Morpholines (MeSH), Médecine traditionnelle chinoise (MeSH), Oséltamivir (usage thérapeutique), Oxazines (usage thérapeutique), Pandémies (MeSH), Pneumopathie virale (traitement médicamenteux), Protéines virales non structurales (métabolisme), Pyrazines (usage thérapeutique), Pyridines (usage thérapeutique), Pyridones (MeSH), Ritonavir (usage thérapeutique), Thiépines (usage thérapeutique), Triazines (usage thérapeutique), Ténofovir (usage thérapeutique).
- MESH :
- analogues et dérivés : AMP, Adénine, Alanine.
- métabolisme : Betacoronavirus, Cysteine endopeptidases, Glycoprotéine de spicule des coronavirus, Protéines virales non structurales.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : AMP, Adénine, Alanine, Amides, Antipaludiques, Antiviraux, Chloroquine, Cobicistat, Emtricitabine, Hydroxychloroquine, Indoles, Lopinavir, Oséltamivir, Oxazines, Pyrazines, Pyridines, Ritonavir, Thiépines, Triazines, Ténofovir.
- Association de médicaments, Association médicamenteuse, Chine, Dibenzothiépines, Découverte de médicament, Essais cliniques comme sujet, Humains, Morpholines, Médecine traditionnelle chinoise, Pandémies, Pyridones.
- Wicri :
- geographic : République populaire de Chine.
English descriptors
- KwdEn :
- Adenine (analogs & derivatives), Adenine (therapeutic use), Adenosine Monophosphate (analogs & derivatives), Adenosine Monophosphate (therapeutic use), Alanine (analogs & derivatives), Alanine (therapeutic use), Amides (therapeutic use), Antimalarials (therapeutic use), Antiviral Agents (therapeutic use), Betacoronavirus (metabolism), COVID-19 (MeSH), China (MeSH), Chloroquine (therapeutic use), Clinical Trials as Topic (MeSH), Cobicistat (therapeutic use), Coronavirus 3C Proteases (MeSH), Coronavirus Infections (drug therapy), Cysteine Endopeptidases (metabolism), Dibenzothiepins (MeSH), Drug Combinations (MeSH), Drug Discovery (MeSH), Drug Therapy, Combination (MeSH), Emtricitabine (therapeutic use), Humans (MeSH), Hydroxychloroquine (therapeutic use), Indoles (therapeutic use), Lopinavir (therapeutic use), Medicine, Chinese Traditional (MeSH), Morpholines (MeSH), Oseltamivir (therapeutic use), Oxazines (therapeutic use), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pyrazines (therapeutic use), Pyridines (therapeutic use), Pyridones (MeSH), RNA-Dependent RNA Polymerase (metabolism), Ritonavir (therapeutic use), SARS-CoV-2 (MeSH), Spike Glycoprotein, Coronavirus (metabolism), Tenofovir (therapeutic use), Thiepins (therapeutic use), Triazines (therapeutic use), Viral Nonstructural Proteins (metabolism).
- MESH :
- chemical , analogs & derivatives : Adenine, Adenosine Monophosphate, Alanine.
- chemical , metabolism : Cysteine Endopeptidases, RNA-Dependent RNA Polymerase, Spike Glycoprotein, Coronavirus, Viral Nonstructural Proteins.
- chemical , therapeutic use : Adenine, Adenosine Monophosphate, Alanine, Amides, Antimalarials, Antiviral Agents, Chloroquine, Cobicistat, Emtricitabine, Hydroxychloroquine, Indoles, Lopinavir, Oseltamivir, Oxazines, Pyrazines, Pyridines, Ritonavir, Tenofovir, Thiepins, Triazines.
- geographic : China, Coronavirus 3C Proteases, Dibenzothiepins, Drug Combinations, Morpholines, Pyridones.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- metabolism : Betacoronavirus.
- COVID-19, Clinical Trials as Topic, Drug Discovery, Drug Therapy, Combination, Humans, Medicine, Chinese Traditional, Pandemics, SARS-CoV-2.
DOI: 10.1016/j.drudis.2020.02.011
PubMed: 32198066
PubMed Central: PMC7102657
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001A56
Links to Exploration step
pubmed:32198066Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Advance of promising targets and agents against COVID-19 in China.</title>
<author><name sortKey="Duan, Yongtao" sort="Duan, Yongtao" uniqKey="Duan Y" first="Yongtao" last="Duan">Yongtao Duan</name>
<affiliation wicri:level="1"><nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhu, Hai Liang" sort="Zhu, Hai Liang" uniqKey="Zhu H" first="Hai-Liang" last="Zhu">Hai-Liang Zhu</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhou, Chongchen" sort="Zhou, Chongchen" uniqKey="Zhou C" first="Chongchen" last="Zhou">Chongchen Zhou</name>
<affiliation wicri:level="1"><nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhouchongchen@163.com.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32198066</idno>
<idno type="pmid">32198066</idno>
<idno type="doi">10.1016/j.drudis.2020.02.011</idno>
<idno type="pmc">PMC7102657</idno>
<idno type="wicri:Area/Main/Corpus">001A56</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001A56</idno>
<idno type="wicri:Area/Main/Curation">001A56</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001A56</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Advance of promising targets and agents against COVID-19 in China.</title>
<author><name sortKey="Duan, Yongtao" sort="Duan, Yongtao" uniqKey="Duan Y" first="Yongtao" last="Duan">Yongtao Duan</name>
<affiliation wicri:level="1"><nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhu, Hai Liang" sort="Zhu, Hai Liang" uniqKey="Zhu H" first="Hai-Liang" last="Zhu">Hai-Liang Zhu</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhou, Chongchen" sort="Zhou, Chongchen" uniqKey="Zhou C" first="Chongchen" last="Zhou">Chongchen Zhou</name>
<affiliation wicri:level="1"><nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhouchongchen@163.com.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Drug discovery today</title>
<idno type="eISSN">1878-5832</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenine (analogs & derivatives)</term>
<term>Adenine (therapeutic use)</term>
<term>Adenosine Monophosphate (analogs & derivatives)</term>
<term>Adenosine Monophosphate (therapeutic use)</term>
<term>Alanine (analogs & derivatives)</term>
<term>Alanine (therapeutic use)</term>
<term>Amides (therapeutic use)</term>
<term>Antimalarials (therapeutic use)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (metabolism)</term>
<term>COVID-19 (MeSH)</term>
<term>China (MeSH)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Clinical Trials as Topic (MeSH)</term>
<term>Cobicistat (therapeutic use)</term>
<term>Coronavirus 3C Proteases (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Cysteine Endopeptidases (metabolism)</term>
<term>Dibenzothiepins (MeSH)</term>
<term>Drug Combinations (MeSH)</term>
<term>Drug Discovery (MeSH)</term>
<term>Drug Therapy, Combination (MeSH)</term>
<term>Emtricitabine (therapeutic use)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Indoles (therapeutic use)</term>
<term>Lopinavir (therapeutic use)</term>
<term>Medicine, Chinese Traditional (MeSH)</term>
<term>Morpholines (MeSH)</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Oxazines (therapeutic use)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pyrazines (therapeutic use)</term>
<term>Pyridines (therapeutic use)</term>
<term>Pyridones (MeSH)</term>
<term>RNA-Dependent RNA Polymerase (metabolism)</term>
<term>Ritonavir (therapeutic use)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Spike Glycoprotein, Coronavirus (metabolism)</term>
<term>Tenofovir (therapeutic use)</term>
<term>Thiepins (therapeutic use)</term>
<term>Triazines (therapeutic use)</term>
<term>Viral Nonstructural Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>AMP (analogues et dérivés)</term>
<term>AMP (usage thérapeutique)</term>
<term>Adénine (analogues et dérivés)</term>
<term>Adénine (usage thérapeutique)</term>
<term>Alanine (analogues et dérivés)</term>
<term>Alanine (usage thérapeutique)</term>
<term>Amides (usage thérapeutique)</term>
<term>Antipaludiques (usage thérapeutique)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Association de médicaments (MeSH)</term>
<term>Association médicamenteuse (MeSH)</term>
<term>Betacoronavirus (métabolisme)</term>
<term>Chine (MeSH)</term>
<term>Chloroquine (usage thérapeutique)</term>
<term>Cobicistat (usage thérapeutique)</term>
<term>Cysteine endopeptidases (métabolisme)</term>
<term>Dibenzothiépines (MeSH)</term>
<term>Découverte de médicament (MeSH)</term>
<term>Emtricitabine (usage thérapeutique)</term>
<term>Essais cliniques comme sujet (MeSH)</term>
<term>Glycoprotéine de spicule des coronavirus (métabolisme)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Indoles (usage thérapeutique)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Lopinavir (usage thérapeutique)</term>
<term>Morpholines (MeSH)</term>
<term>Médecine traditionnelle chinoise (MeSH)</term>
<term>Oséltamivir (usage thérapeutique)</term>
<term>Oxazines (usage thérapeutique)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Protéines virales non structurales (métabolisme)</term>
<term>Pyrazines (usage thérapeutique)</term>
<term>Pyridines (usage thérapeutique)</term>
<term>Pyridones (MeSH)</term>
<term>Ritonavir (usage thérapeutique)</term>
<term>Thiépines (usage thérapeutique)</term>
<term>Triazines (usage thérapeutique)</term>
<term>Ténofovir (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adenine</term>
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cysteine Endopeptidases</term>
<term>RNA-Dependent RNA Polymerase</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Nonstructural Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adenine</term>
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Amides</term>
<term>Antimalarials</term>
<term>Antiviral Agents</term>
<term>Chloroquine</term>
<term>Cobicistat</term>
<term>Emtricitabine</term>
<term>Hydroxychloroquine</term>
<term>Indoles</term>
<term>Lopinavir</term>
<term>Oseltamivir</term>
<term>Oxazines</term>
<term>Pyrazines</term>
<term>Pyridines</term>
<term>Ritonavir</term>
<term>Tenofovir</term>
<term>Thiepins</term>
<term>Triazines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term>
<term>Coronavirus 3C Proteases</term>
<term>Dibenzothiepins</term>
<term>Drug Combinations</term>
<term>Morpholines</term>
<term>Pyridones</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>AMP</term>
<term>Adénine</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Betacoronavirus</term>
<term>Cysteine endopeptidases</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Protéines virales non structurales</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>AMP</term>
<term>Adénine</term>
<term>Alanine</term>
<term>Amides</term>
<term>Antipaludiques</term>
<term>Antiviraux</term>
<term>Chloroquine</term>
<term>Cobicistat</term>
<term>Emtricitabine</term>
<term>Hydroxychloroquine</term>
<term>Indoles</term>
<term>Lopinavir</term>
<term>Oséltamivir</term>
<term>Oxazines</term>
<term>Pyrazines</term>
<term>Pyridines</term>
<term>Ritonavir</term>
<term>Thiépines</term>
<term>Triazines</term>
<term>Ténofovir</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Clinical Trials as Topic</term>
<term>Drug Discovery</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Medicine, Chinese Traditional</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term>
<term>Association médicamenteuse</term>
<term>Chine</term>
<term>Dibenzothiépines</term>
<term>Découverte de médicament</term>
<term>Essais cliniques comme sujet</term>
<term>Humains</term>
<term>Morpholines</term>
<term>Médecine traditionnelle chinoise</term>
<term>Pandémies</term>
<term>Pyridones</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32198066</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5832</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>5</Issue>
<PubDate><Year>2020</Year>
<Month>05</Month>
</PubDate>
</JournalIssue>
<Title>Drug discovery today</Title>
<ISOAbbreviation>Drug Discov Today</ISOAbbreviation>
</Journal>
<ArticleTitle>Advance of promising targets and agents against COVID-19 in China.</ArticleTitle>
<Pagination><MedlinePgn>810-812</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1359-6446(20)30098-2</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drudis.2020.02.011</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName>
<ForeName>Yongtao</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhu</LastName>
<ForeName>Hai-Liang</ForeName>
<Initials>HL</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhou</LastName>
<ForeName>Chongchen</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhouchongchen@163.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Drug Discov Today</MedlineTA>
<NlmUniqueID>9604391</NlmUniqueID>
<ISSNLinking>1359-6446</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000577">Amides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003988">Dibenzothiepins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007211">Indoles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009025">Morpholines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010078">Oxazines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011719">Pyrazines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011728">Pyridones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013846">Thiepins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014227">Triazines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000613801">emtricitabine tenofovir alafenamide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C558899">lopinavir-ritonavir drug combination</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>2494G1JF75</RegistryNumber>
<NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3QKI37EEHE</RegistryNumber>
<NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4G86Y4JT3F</RegistryNumber>
<NameOfSubstance UI="C000628402">baloxavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>93M09WW4RU</RegistryNumber>
<NameOfSubstance UI="C086979">umifenovir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>99YXE507IL</RegistryNumber>
<NameOfSubstance UI="D000068698">Tenofovir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber>
<NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber>
<NameOfSubstance UI="D000086782">Coronavirus 3C Proteases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EW5GL2X7E0</RegistryNumber>
<NameOfSubstance UI="C462182">favipiravir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>G70B4ETF4S</RegistryNumber>
<NameOfSubstance UI="D000068679">Emtricitabine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>JAC85A2161</RegistryNumber>
<NameOfSubstance UI="D000225">Adenine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>LW2E03M5PG</RegistryNumber>
<NameOfSubstance UI="D000069547">Cobicistat</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>O3J8G9O825</RegistryNumber>
<NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber>
<NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000225" MajorTopicYN="N">Adenine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000577" MajorTopicYN="N">Amides</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000069547" MajorTopicYN="N">Cobicistat</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086782" MajorTopicYN="N">Coronavirus 3C Proteases</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003988" MajorTopicYN="N">Dibenzothiepins</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068679" MajorTopicYN="N">Emtricitabine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008516" MajorTopicYN="N">Medicine, Chinese Traditional</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009025" MajorTopicYN="N">Morpholines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010078" MajorTopicYN="N">Oxazines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011719" MajorTopicYN="N">Pyrazines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011728" MajorTopicYN="N">Pyridones</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012324" MajorTopicYN="N">RNA-Dependent RNA Polymerase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068698" MajorTopicYN="N">Tenofovir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013846" MajorTopicYN="N">Thiepins</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014227" MajorTopicYN="N">Triazines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32198066</ArticleId>
<ArticleId IdType="pii">S1359-6446(20)30098-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.drudis.2020.02.011</ArticleId>
<ArticleId IdType="pmc">PMC7102657</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Feb 19;368:m606</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075786</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2020 Mar 27;367(6485):1444-1448</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32132184</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001A56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:32198066 |texte= Advance of promising targets and agents against COVID-19 in China. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:32198066" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |